Capital Research Global Investors’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-6,113,768
Closed -$55.3M 445
2013
Q4
$55.3M Hold
6,113,768
0.02% 329
2013
Q3
$38.6M Sell
6,113,768
-284,405
-4% -$1.79M 0.02% 361
2013
Q2
$43.6M Buy
+6,398,173
New +$43.6M 0.02% 330